Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Consulting Reports / Office of Health Economics

Citation Profile [Updated: 2020-06-03 07:38:54]
5 Years H
3
Impact Factor
0.25
5 Years IF
0.18
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.13 0 0 0 0 0 0 0 0 0 0 0.07
1991 0 0.11 0 0 0 0 0 0 0 0 0 0 0.06
1992 0 0.1 0 0 0 0 0 0 0 0 0 0 0.07
1993 0 0.13 0 0 0 0 0 0 0 0 0 0 0.07
1994 0 0.13 0 0 0 0 0 0 0 0 0 0 0.06
1995 0 0.19 0 0 0 0 0 0 0 0 0 0 0.09
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.12
1997 0 0.23 0 0 0 0 0 0 0 0 0 0 0.12
1998 0 0.24 0 0 0 0 0 0 0 0 0 0 0.15
1999 0 0.32 0 0 0 0 0 0 0 0 0 0 0.21
2000 0 0.47 0 0 0 0 0 0 0 0 0 0 0.2
2001 0 0.4 0 0 0 0 0 0 0 0 0 0 0.22
2002 0 0.41 0 0 0 0 0 0 0 0 0 0 0.23
2003 0 0.42 0 0 0 0 0 0 0 0 0 0 0.24
2004 0 0.47 0 0 0 0 0 0 0 0 0 0 0.27
2005 0 0.49 0 0 1 1 0 0 0 0 0 0 0.29
2006 0 0.48 0 0 1 2 0 0 1 1 0 0 0.27
2007 0 0.41 0 0 0 2 0 0 2 2 0 0 0.22
2008 0 0.46 0 0 1 3 0 0 1 2 0 0 0.23
2009 0 0.43 0 0 2 5 0 0 1 3 0 0 0.23
2010 0.33 0.37 0.11 0.2 4 9 0 1 1 3 1 5 1 0 0 0.2
2011 0 0.47 0 0 3 12 5 1 6 8 0 0 0.25
2012 0 0.5 0 0 3 15 0 1 7 10 0 0 0.26
2013 0.17 0.52 0.07 0.08 0 15 0 1 2 6 1 13 1 0 0 0.24
2014 0 0.54 0.11 0.08 3 18 5 2 4 3 12 1 0 1 0.33 0.28
2015 1 0.54 0.17 0.23 5 23 5 4 8 3 3 13 3 1 25 1 0.2 0.28
2016 0 0.57 0.04 0.07 4 27 0 1 9 8 14 1 0 0 0.29
2017 0.11 0.58 0.15 0.07 7 34 4 5 14 9 1 15 1 2 40 1 0.14 0.28
2018 0.27 0.6 0.23 0.42 9 43 3 10 24 11 3 19 8 1 10 2 0.22 0.31
2019 0.25 0.65 0.15 0.18 3 46 0 7 31 16 4 28 5 1 14.3 0 0.38
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192.

Full description at Econpapers || Download paper

6
22014The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050.

Full description at Econpapers || Download paper

4
32015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576.

Full description at Econpapers || Download paper

3
42018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

3
52017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802.

Full description at Econpapers || Download paper

2
62014The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cockcroft, L ; Sussex, J ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518.

Full description at Econpapers || Download paper

2
72015Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660.

Full description at Econpapers || Download paper

2
82010Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Puig-Peiro, R ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000212.

Full description at Econpapers || Download paper

1
92017Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Zamora, Bernarda ; Garau, Martina ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818.

Full description at Econpapers || Download paper

1
102015Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cole, Amanda ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595.

Full description at Econpapers || Download paper

1
112018A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Shaw, B ; Hernandez-Villafuerte, K ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002015.

Full description at Econpapers || Download paper

1
122012The Many Faces of Innovation. (2012). Sussex, J ; Mordoh, A ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000154.

Full description at Econpapers || Download paper

1
132017Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784.

Full description at Econpapers || Download paper

1
142016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Cubi-Molla, Patricia. In: Consulting Reports. RePEc:ohe:conrep:001699.

Full description at Econpapers || Download paper

1
152008Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236.

Full description at Econpapers || Download paper

1
162017Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

3
22011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192.

Full description at Econpapers || Download paper

2
32017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802.

Full description at Econpapers || Download paper

2
42014The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050.

Full description at Econpapers || Download paper

2
52015Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660.

Full description at Econpapers || Download paper

2
62015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 4
YearTitle
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108.

Full description at Econpapers || Download paper

2019Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare. (2019). Hampson, Grace ; Wong, Olivier ; Schulenburg, J-Matthias Graf ; Towse, Adrian ; Michaels, Jonathan ; Jonsson, Bengt. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:3:d:10.1007_s10198-018-1007-x.

Full description at Econpapers || Download paper

2019Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?. (2019). Zamora, B ; Towse, A ; Cole, A. In: Briefings. RePEc:ohe:briefg:002165.

Full description at Econpapers || Download paper

2019The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment. (2019). Brassel, Simon ; Towse, A ; Rozanova, O. In: Research Papers. RePEc:ohe:respap:002154.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2018
YearCiting document
2018Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals. (2018). Lorgelly, Paula ; Cole, Amanda ; Sullivan, R ; Towse, A. In: Research Papers. RePEc:ohe:respap:002030.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

Recent citations received in 2017
YearCiting document
2017Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study. (2017). Garau, Martina ; Garrison, L ; Towse, T ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001781.

Full description at Econpapers || Download paper